April 13 (Reuters) - Allogene Therapeutics (ALLO.O), opens new tab said on Monday that interim data from a mid-stage study showed its experimental off-the-shelf CAR-T therapy reduced the risk of ...
April 13 (Reuters) - Spyre Therapeutics (SYRE.O), opens new tab said on Monday its experimental drug showed a significant reduction in disease activity when tested in patients with ulcerative colitis ...
A student has been charged with allegedly photographing the JEE Main 2026 question paper and attempting to circulate it during the examination at a Manipal center on April 5. Manipal: A student has ...
Confused between Python and R? Discover which language dominates data science in 2026. Compare AI power, visualization, and real-world use cases to pick the right career path. Whether beginner or pro, ...
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
A new study from Monash University reveals that adults with Attention-Deficit/Hyperactivity Disorder (ADHD) experience brief sleep-like brain activity during the day ...
The Indian summer monsoon may change under the impact of global warming, potentially returning to conditions similar to the mid-Pliocene era, according to research by the National Institute of ...
In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...
Sanofi has backed the $75 million series B of a rhinovirus-focused biotech with a former FDA acting commissioner at the helm. Altesa BioSciences unveiled back in 2022 with $4 million in seed funding ...
The lineup for Turning Point USA's "All-American Halftime Show" is finally here. The show, put on by the conservative organization to compete with Bad Bunny's Super Bowl halftime performance, will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results